Disruption of the β3 663-687 disulfide bridge confers constitutive activity to β3 integrins
Open Access
- 1 October 2003
- journal article
- Published by American Society of Hematology in Blood
- Vol. 102 (7) , 2491-2497
- https://doi.org/10.1182/blood-2003-01-0213
Abstract
The platelet fibrinogen receptor, integrin αIIbβ3, is a noncovalent heterodimer of glycoproteins IIb and IIIa. This work was aimed at elucidating the role played by the carboxy-terminal extracellular, trans-membrane, and cytoplasmic regions of the glycoprotein β3 in the formation of functional complexes with α subunits. Progressive carboxy-terminal deletions of β3 revealed that surface exposure of αIIbβ3 or αvβ3 could not occur in the absence of the transmembrane domain of β3. In contrast, internal deletions 616 to 690 of the carboxy-terminal regions of the β3 ectodomain led to surface exposure of constitu tive active receptors in CHO cells, as indicated by the enhanced rate of cell adhesion to immobilized ligands and spontaneous binding to soluble fibrinogen or activation-dependent antibody PAC-1. The functional analysis of cysteine mutations within the 616 to 690 region of β3 or chimeric β3-β7 subunits revealed that disruption of the C663-C687 disulfide bridge endows constitutive activity to the αIIbβ3 receptor. It is concluded that the carboxy-terminal tail of the β3 ectodomain, so-called β tail domain (βTD), is not essential for cell surface expression of β3 receptors. However, a basal, nonactivated, low ligand-affinity state of the β3 integrins demands a normal conformation of this domain. (Blood. 2003;102:2491-2497)Keywords
This publication has 53 references indexed in Scilit:
- Integrin Activation Involves a Conformational Change in the α1 Helix of the β Subunit A-domainJournal of Biological Chemistry, 2002
- A point mutation in the cysteine-rich domain of glycoprotein (GP) IIIa results in the expression of a GPIIb-IIIa (αIIbβ3) integrin receptor locked in a high-affinity state and a Glanzmann thrombasthenia–like phenotypeBlood, 2001
- Crystal Structure of the Extracellular Segment of Integrin αVβ3Science, 2001
- Probing Conformational Changes in the I-like Domain and the Cysteine-rich Repeat of Human β3 Integrins following Disulfide Bond Disruption by Cysteine MutationsJournal of Biological Chemistry, 2001
- Three Novel Integrin β3 Subunit Missense Mutations (H280P, C560F, and G579S) in Thrombasthenia, Including One (H280P) Prevalent in Japanese PatientsBiochemical and Biophysical Research Communications, 1998
- Truncation of the cytoplasmic domain of beta3 in a variant form of Glanzmann thrombasthenia abrogates signaling through the integrin alpha(IIb)beta3 complex.Journal of Clinical Investigation, 1997
- Agonist-activated αvμ3 on Platelets and Lymphocytes Binds to the Matrix Protein OsteopontinJournal of Biological Chemistry, 1997
- Activation of the Integrin αvβ3 Involves a Discrete Cation-binding Site That Regulates ConformationPublished by Elsevier ,1996
- Integrins: Emerging Paradigms of Signal TransductionAnnual Review of Cell and Developmental Biology, 1995
- Involvement of α6β3 Integrin in Mediating Fibrin Gel RetractionJournal of Biological Chemistry, 1995